DCT

1:24-cv-00775

Novo Nordisk Inc v. Mylan Pharma Inc

General
Filed
07/01/24
Cause of ActionPatent Infringement
SectorBiotech
Status
Closed (09/11/24)
Patent Owner
NPE (L)
Nature of Suit835 ANDA
Judge
Period
PO Win Rate
07/03/24 - 10/03/24
44%
Plaintiff
Party
No Parties
Defendant
Party
No Parties
Attorney
No Attorneys